Nephrolithiasis Clinical Trial
Official title:
Brushite Stones: A Registry and Database of Clinical and Laboratory Findings
Brushite kidney stones are a unique form of calcium phosphate stones that have a tendency to recur quickly if patients are not aggressively treated with stone prevention measures. Little research has been undertaken to better understand the clinical history and potential urinary abnormalities that may predispose one to these troublesome kidney stones.
Multiple treatment options are available for the treatment of kidney or ureteral calculi.
Treatment options include shock wave lithotripsy (SWL; shock waves are transmitted through
the body wall and focused onto the stone to break the stone into gravel), percutaneous
nephrolithotomy (PNL; a small flank incision is made and a telescope inserted into the
kidney to allow stone fragmentation and removal from the patient), and ureteroscopic
lithotripsy (URS; a small telescope is inserted into the ureter or kidney and a laser is
used to break up the stone into gravel).
Brushite is a unique form of calcium phosphate kidney stone that often has sub-optimal stone
fragmentation with shock wave lithotripsy (Heimbach et al, 1999). Due to its SWL resistance,
brushite patients often undergo more invasive treatments such as URS or PNL to achieve a
stone free status. Brushite patients often have multiple stones and have a high likelihood
of developing recurrences (new stone formation or regrowth of existing stone fragments),
often within the first year after surgery. These patients may also have a history of
anatomical abnormalities of the urinary tract or a history of prior renal or ureteral
surgery (Klee et al, 1991).
A thorough review of the clinical, radiological and metabolic data of brushite patients has
the potential to clarify a number of important points. Many patients with brushite stones
often have a history of non-brushite stones (e.g. calcium oxalate) predating the development
of brushite stones and historical review is needed to define the factors contributing to
this shift in stone composition. In addition, it has been shown that CT attenuation values
can be used to predict stone composition (Joseph et al, 2002). As a result, it is crucial to
review the radiologic appearance of known brushite stones to identify specific radiographic
characteristics and possibly allow a radiographic diagnosis of brushite to be established.
Finally, very little information has been reported on the urinary abnormalities in brushite
patients. By carefully examining 24 hour urine data in a large population of brushite
patients, information may be identified that can be used to provide improved management of
specific abnormalities to prevent stone recurrences.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT03692715 -
Antibiotic Prophylaxis Before Shock Wave Lithotripsy
|
Phase 4 | |
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02289755 -
Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
|
Phase 2 | |
Completed |
NCT01690039 -
Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis
|
||
Completed |
NCT01650935 -
Comparison of DASH With Oxalate Restricted Diet on Urine in Recurrent Stone Formers With Hyperoxaluria
|
N/A | |
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Recruiting |
NCT05014178 -
Kidney Sodium Functional Imaging
|
||
Not yet recruiting |
NCT06199102 -
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
|
N/A | |
Recruiting |
NCT04367155 -
Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.
|
N/A | |
Recruiting |
NCT04374188 -
Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Recruiting |
NCT04389853 -
Mini-PNCL vs fURS in Management of Nephrolithiasis
|
N/A | |
Completed |
NCT03348228 -
Effect of Hydroxycitrate on Urine Chemistry
|
N/A | |
Completed |
NCT05350423 -
Trial Assessing Renal Damage During Ureteroscopy
|
N/A | |
Completed |
NCT03454139 -
Subcostal TAP Block For Percutaneous Nephrolithotomy
|
N/A | |
Recruiting |
NCT02279927 -
Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy
|
N/A | |
Completed |
NCT02276924 -
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
|
N/A | |
Completed |
NCT00159393 -
Percutaneous Nephrolithotomy: A Registry and Database
|